Hematological Diseases

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)

Late Effects and HRQoL in Survivors of Allo-HSCT - a Cross Sectional Study

A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation

Assessment of Admission to the ICU of Onco-hematological Patients.

Testing Content Delivery Models for MomConnect

Allo HSCT Using RIC for Hematological Diseases

XIENCE 28 USA Study

Secure Outsourcing of Carfilzomib in the Treatment of Multiple Myeloma to the Hospital at Home Setting

Carbapenem-resistant Organisms (CRO) Screening From Rectal Swabs in Patients With Hematological Diseases in China

Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex®) in Patients at High Risk of Carrying Blood Diseases

Daily Ginger Drinking and Platelet Function

Study on Systemic and Airway Biomarkers in Haemopoietic Stem Cell Transplantation

MSC for Treatment of CMV Infection

Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases

MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment

Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia

Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function

Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?

Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure